In skeletal muscle, our results show that pretreatment with the nutraceutical ameliorates the stimulatory effect of sepsis on the gene expression of the proteolytic markers atrogin-1 and MuRF1, as well as on the mRNA levels of LC3b, myogenin and HDAC4. The gene discussed is TRIM63; the disease is Sepsis.